Alps Advisors Inc Immunocore Holdings PLC Transaction History

Alps Advisors Inc

$17.2 Billion
Q1 2025

A detailed history of Alps Advisors Inc transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Alps Advisors Inc holds 35,836 shares of IMCR stock, worth $1.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

35,836

Previous 40,454 11.42%

Holding current value

$1.08 Million

Previous $1.19 Million 10.9%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	SELL	$28.21 - $33.0 $130,273 - $152,394	-4,618 Reduced 11.42%	35,836 $1.06 Million
Q4 2024 Feb 13, 2025	BUY	$28.14 - $34.69 $59,206 - $72,987	2,104 Added 5.49%	40,454 $1.19 Million
Q3 2024 Nov 12, 2024	BUY	$30.06 - $41.49 $8,717 - $12,032	290 Added 0.76%	38,350 $1.19 Million
Q2 2024 Aug 13, 2024	BUY	$33.78 - $63.75 $98,806 - $186,468	2,925 Added 8.33%	38,060 $1.29 Million
Q1 2024 May 14, 2024	BUY	$60.14 - $75.36 $104,944 - $131,503	1,745 Added 5.23%	35,135 $2.28 Million
Q4 2023 Feb 14, 2024	SELL	$42.85 - $69.5 $119,037 - $193,071	-2,778 Reduced 7.68%	33,390 $2.28 Million
Q3 2023 Nov 14, 2023	SELL	$49.5 - $66.6 $48,856 - $65,734	-987 Reduced 2.66%	36,168 $1.88 Million
Q2 2023 Aug 14, 2023	BUY	$48.54 - $61.64 $265,805 - $337,540	5,476 Added 17.29%	37,155 $2.23 Million
Q1 2023 May 10, 2023	BUY	$46.12 - $65.71 $45,382 - $64,658	984 Added 3.21%	31,679 $1.57 Million
Q4 2022 Feb 14, 2023	BUY	$45.51 - $65.08 $306,600 - $438,443	6,737 Added 28.12%	30,695 $1.75 Million
Q3 2022 Nov 14, 2022	SELL	$37.34 - $57.44 $58,549 - $90,065	-1,568 Reduced 6.14%	23,958 $1.13 Million
Q2 2022 Aug 11, 2022	SELL	$25.46 - $37.72 $476,102 - $705,364	-18,700 Reduced 42.28%	25,526 $952,000
Q1 2022 May 16, 2022	SELL	$18.94 - $34.29 $122,049 - $220,964	-6,444 Reduced 12.72%	44,226 $1.32 Million
Q4 2021 Feb 09, 2022	SELL	$27.58 - $40.0 $82,546 - $119,720	-2,993 Reduced 5.58%	50,670 $1.74 Million
Q3 2021 Nov 15, 2021	SELL	$27.98 - $40.0 $101,007 - $144,400	-3,610 Reduced 6.3%	53,663 $1.99 Million
Q2 2021 Aug 11, 2021	BUY	$32.22 - $41.5 $1.85 Million - $2.38 Million	57,273 New	57,273 $2.24 Million

Others Institutions Holding IMCR

# of Institutions

124

Shares Held

35.9M

Call Options Held

79.9K

Put Options Held

46.2K

View Full List

About Immunocore Holdings plc

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.32B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

More about IMCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Immunocore Holdings PLC Transaction History